Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2011
11/09/2011CN101850043B Application of crex rigescens in preparation of medicament for resisting respiratory syncytial virus
11/09/2011CN101773507B Cefepime hydrochloride/arginine pharmaceutical composition suspension injection
11/09/2011CN101766751B Prescription of modified zinc oxide with vinegar-soaked mashed garlic for onychomycosis treatment
11/09/2011CN101759598B Tetracycline compound with amino acid amidine
11/09/2011CN101721505B Aruncus dioicus extractive with function of antibacterial activity
11/09/2011CN101721488B Pharmaceutical composition for treating liver diseases and prepration method thereof
11/09/2011CN101716230B Complex preparation of stephanotis and antibiotic for treating infectious disease
11/09/2011CN101700234B Flucloxacillin sodium suspension and new application thereof
11/09/2011CN101693713B New crystal system of entecavir, preparation process and medicament application thereof
11/09/2011CN101684101B Piperazinone substituted tetracycline derivatives
11/09/2011CN101658485B Nanometer hybridized hydrogel with durable broad spectrum antibacterial performance and preparation method thereof
11/09/2011CN101653531B Anti-respiratory virus traditional Chinese medicine composite and preparation method and application thereof
11/09/2011CN101638385B Novel carbostyril derivative and preparation and application thereof
11/09/2011CN101633910B Rotavirus gene recombined strain and construction method and application thereof
11/09/2011CN101618018B Miconazole nitrate particle, and preparation method and medicinal composition thereof
11/09/2011CN101612394B Streptococcus-pneumoniae-toxicity-reducing live vaccine
11/09/2011CN101584703B Pharmaceutical composition for treating colpitis and preparation method thereof
11/09/2011CN101502510B Medicament composition for treating colpitis symptoms and preparation method thereof
11/09/2011CN101486720B Method for synthesizing cefodizime sodium compound
11/09/2011CN101481317B L-N-substituted-3-pinane, synthesis and use thereof
11/09/2011CN101443332B Anti-viral pyrimidine nucleoside derivatives
11/09/2011CN101433621B Chinese medicinal composition for treating asthma of pig as well as preparation method and use thereof
11/09/2011CN101406613B Use of Chinese medicinal composition in preparing medicament for treating vital myocarditis
11/09/2011CN101317928B Orally taken traditional Chinese medicine for treating gonorrhoea of children
11/09/2011CN101112408B Sustained-release ji chrysanthemum tablet and method for preparing the same
11/09/2011CN101104055B Internal-applied traditional Chinese medicine for treating common cold
11/08/2011USRE42902 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use
11/08/2011US8053473 Antibacterial agent comprising 7, 10-dihydroxy-8(E)-octadecenoic acid
11/08/2011US8053436 9-(piperazinylalkyl) carbazoles as bax-modulators
11/08/2011US8053206 Antagonists of HMG1 for treating inflammatory conditions
11/08/2011US8052984 Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages
11/08/2011US8052981 Mono- and disaccharide derivatives
11/08/2011US8052975 Compounds and methods for treatment and diagnosis of chlamydial infection
11/08/2011CA2535637C Quinolone antibiotics for the systemic treatment of bacterial infections of the oral cavity
11/08/2011CA2524069C Substituted dihydroquinazolines
11/08/2011CA2507131C .beta.-1,4-mannobiose-containing composition
11/08/2011CA2493690C Synthetic c-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases
11/08/2011CA2460572C Dual action antibiotics
11/08/2011CA2459230C Peptidic compounds selectively binding to p-selectin
11/08/2011CA2451552C Topical application of thiazolylamides
11/08/2011CA2442539C Method and composition for solubilising a biologically active compound with low water solubility
11/08/2011CA2436180C Immunoregulatory antibodies and uses thereof
11/08/2011CA2431675C Novel sulfamides and their use as endothelin receptor antagonists
11/08/2011CA2415399C Use of strains of the parapox ovis virus against organ fibrosis
11/08/2011CA2362204C Immunogenic complexes and methods relating thereto
11/08/2011CA2343414C Fc receptor modulators and uses thereof
11/08/2011CA2153692C Recombinant anti-vla4 antibody molecules
11/03/2011WO2011137428A1 Methods of treating hiv infection: inhibition of dna dependent protein kinase
11/03/2011WO2011137376A2 Compounds for anti-fungal treatment
11/03/2011WO2011137319A2 Stabilized fibronectin domain compositions, methods and uses
11/03/2011WO2011137181A1 Synthetic oligosaccharides for moraxella vaccine
11/03/2011WO2011136268A1 Novel cephem derivative
11/03/2011WO2011136247A1 Novel heteroaryl monocyclic pyrimidine derivative
11/03/2011WO2011136174A1 Depsipeptide compound
11/03/2011WO2011135743A1 Medicinal agent for prevention and/or treatment of hepatitis c
11/03/2011WO2011135734A1 Complex of virus, therapeutic agent comprising same, and therapeutic method
11/03/2011WO2011135578A1 Composition comprising chitin and tinosporin for use in the treatment of viral diseases
11/03/2011WO2011135563A1 Metal entrapped bioactive composites
11/03/2011WO2011134538A1 Diyne compositions
11/03/2011WO2011134439A1 Specific anti-viral antisense nucleic acid drug for avian influenza virus
11/03/2011WO2011134296A1 (6,7-dihydro-2-nitro-5h-imidazol[2,1-b] [1,3]oxazin-6-yl) amide compounds, preparation methods and uses thereof
11/03/2011WO2011134283A1 Matrinic acid/ matrine derivatives and preparation methods and uses thereof
11/03/2011WO2011134280A1 Compounds as agonists of s1p1 receptors
11/03/2011WO2011134271A1 Use of kukoamine a and kukoamine b
11/03/2011WO2011134163A1 Preparation method for inactivated vaccine of h9n2 subtype avian influenza and the product thereof
11/03/2011WO2011133997A1 Cross-protective influenza vaccines
11/03/2011WO2011110655A3 Immunogenic composition or vaccine against gram - negative bacterial, for example neiserial, infection or disease
11/03/2011WO2011082400A3 Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
11/03/2011WO2011074782A3 Liposome composition, preparation method thereof, and usage of the composition as pneumonia vaccine
11/03/2011WO2011060440A3 Kinase inhibitors
11/03/2011WO2011055931A3 Composition for preventing or treating diseases caused by influenza viruses
11/03/2011WO2011049914A3 Anti-hiv peptides and methods of use thereof
11/03/2011WO2011046623A3 Hiv-1 antibodies
11/03/2011WO2011043631A3 Pharmaceutical composition for preventing and treating cold, containing reynoutria elliptica extract, fraction thereof or stilbene-based compound
11/03/2011WO2011008863A8 Stereoisomer peptides and their polymer conjugates for hiv disease
11/03/2011WO2010132760A9 Antibacterial derivatives of tobramycin
11/03/2011US20110271358 Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor
11/03/2011US20110271356 Hcv entry factor, occludin
11/03/2011US20110270259 Paste-powder dual polymer-based bone cement and injection apparatus for same
11/03/2011US20110270212 Pharmacokinetic control for optimized interferon delivery
11/03/2011US20110270151 Image-guided energy deposition for targeted drug delivery
11/03/2011US20110269950 PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
11/03/2011US20110269834 Compounds and methods for treating respiratory diseases
11/03/2011US20110269816 Inhibition of Viral Gene Expression Using Small Interfering RNA
11/03/2011US20110269803 Azole compounds used as tuberculostatic and leishmanicide agents
11/03/2011US20110269794 External Preparation for Athlete's Foot Treatment
11/03/2011US20110269760 Tubulin inhibitors
11/03/2011US20110269758 Naphthyridinones as protein kinase inhibitors
11/03/2011US20110269741 Novel compositions and methods of use
11/03/2011US20110269739 Kinase inhibitors
11/03/2011US20110269738 Compounds
11/03/2011US20110269731 Nanoparticles of beta-lactam derivatives
11/03/2011US20110269720 Minocycline and rifampin microparticles
11/03/2011US20110269719 Pharmaceutical compositions with phosphonium antimicrobial agents
11/03/2011US20110269714 Polycyclic Tetracycline Compounds
11/03/2011US20110269709 Prodrugs containing novel bio-cleavable linkers
11/03/2011US20110269707 Modified nucleosides for the treatment of viral infections and abnormal cellullar proliferation
11/03/2011US20110269704 Method for developing a liquid composition to be applied to the skin as a foam and a composition that can be applied topically
11/03/2011US20110269689 High penetration compositions and their applications
11/03/2011US20110269677 Oligomer-Protease Inhibitor Conjugates